
Daily Derm Times: June 5, 2025
Key Takeaways
- Lichen planus care requires collective investment and action to advance research and treatment strategies.
- Acne is increasingly seen as a chronic condition, necessitating innovative treatment approaches and equitable care access.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our
Calling for Collective Investment and Action in Lichen Planus Care
In part 3 of this conversation, Adam Friedman, MD, FAAD, discusses the need for unity in advancing lichen planus care and research.
The Growing Burden of Acne in America: Time to Rethink Our Approach
Acne is increasingly recognized as a chronic condition, affecting diverse populations and demanding innovative treatment strategies and equitable care access.
Targeted TYK2 Blockade for PsO Without JAK1/2/3 Impact
Zasocitinib emerges as a promising oral therapy for psoriasis and psoriatic arthritis, showcasing superior selectivity and safety compared to traditional JAK inhibitors.
Tristan Hasbargen, PA-C, Builds Surgical Skills and Support at Fall Clinical PA/NP
Tristan Hasbargen, PA-C, led a hands-on suturing workshop at the Fall Clinical NP/PA Conference, enhancing skills in surgical dermatology.
Novel OS-01 Peptide Body Lotion Reduces Inflammation and Strengthens Skin Barrier
The OS-01 peptide formulation enhanced skin barrier function and reduced inflammation, showing promising results in a 12-week clinical trial.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















